Events Archives - Page 64 of 128

1 minute read

Minority Equality Opportunities Acquisition Inc. Announces Postponement Of Special Meeting Of Shareholders Until Friday, May 26, 2023 At 10:00 a.m. EDT

May 24, 10:12 AM

Minority Equality Opportunities Acquisition Inc. (NASDAQ:MEOA) ("MEOA" or the "Company"), a special purpose acquisition company, filed a definitive proxy statement / final prospectus with respect to a

MEOA

3 minute read

Top-Notch Companies Attend Canaccord Genuity’s 7th Annual Cannabis Conference In The Big Apple

By Maureen Meehan

May 23, 5:36 PM

Canadian licensed producers, leading U.S. multi-state operators (MSOs), private-sector operators, cannabis retailers, international exporters, accessory manufacturers and other cannabis-focused financial companies all got red-carpet treatment in the Big Apple at Canaccord Genuity's 7th Annual Cannabis Conference.

AAWH

2 minute read

Bar Rescue’s Jon Taffer Explains Why Disney Is So Successful: ‘If You Saw Who Was In That Costume, You Would Die’

By Adam Eckert

May 23, 5:00 PM

Jon Taffer, entrepreneur and star of Paramount Global's (NASDAQ: PARA) "Bar Rescue," believes Walt Disney Co (NYSE: DIS) is the master of business.

DIS

5 minute read

Phase 2 Data from “ASTRAEUS” Trial Of Mereo BioPharma’s Alvelestat In Alpha-1 Antitrypsin Deficiency-Associated Lung Disease Presented At The 2023 American Thoracic Society International Conference

By Benzinga Newsdesk

May 23, 1:45 PM

Mereo BioPharma Group plc (NASDAQ:MREO), ("Mereo" or "the Company"), a clinical-stage biopharmaceutical company focused on rare diseases today announced that data from the Phase 2 "ASTRAEUS" trial of alvelestat for the

MREO

3 minute read

Wall Street Banter At SALT iConnections NYC 2023: Insights, Outlooks From Industry Leaders

By Renato Capelj

May 22, 5:24 PM

Last week, SALT and iConnections held a conference at The Glasshouse in NYC. The event provided thought leaders with a platform to share insights on the future of innovation, investing and global financial trends. Here are some key takeaways and perspectives.

1 minute read

Terns Pharmaceuticals To Highlight New Preclinical Data For TERN-601 Program In Obesity At The American Diabetes Association’s 83rd Annual Scientific Sessions

By Happy Mohamed

May 22, 4:13 PM

Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious

TERN

4 minute read

Aerovate Therapeutics Presents Nonclinical Pharmacokinetic Data In Support Of AV-101, A Novel Dry Powder Inhaled Formulation Of Imatinib, At The American Thoracic Society 2023 International Conference

By Happy Mohamed

May 22, 1:29 PM

Direct delivery of imatinib to the lungs in nonclinical species demonstrated increased lung exposure compared with oral or IV dosing Formulation impacted lung exposure with dry powder demonstrating greater lung

AVTE

2 minute read

Events
News

Synaptics Showcases AI-Enabled Vega Technology For Intuitive And Responsive Haptic Trackpads At Dell Technologies World

By Benzinga Newsdesk

May 22, 9:46 AM

Synaptics® Incorporated (Nasdaq: SYNA) today announced that it is showcasing its Vega capacitive touch- and force-sensing technology with integrated haptics for intuitive and responsive trackpads at Dell

SYNA

5 minute read

Keros Therapeutics Presents Preclinical And Clinical Data From Its KER-012 Program At The American Thoracic Society International Conference

By Benzinga Newsdesk

May 22, 9:14 AM

Keros Therapeutics, Inc. ("Keros") (NASDAQ:KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological,

KROS

2 minute read

MiNK Presents Clinical Data On Allogeneic iNKT Cells In Severe Respiratory Distress At The American Thoracic Society International Conference

By Benzinga Newsdesk

May 22, 8:41 AM

75% survival in patients with severe respiratory distress treated with agenT-797agenT-797 improved lung function, significantly reduced inflammation and secondary infectionsMiNK to advance agenT-797 in ARDS through

INKT